LMNA and progeroid syndrome: Farnesylated progerin exerts a dominant-negative effect in cells and animal models of HGPS [5], and there is increasing evidence that disease severity and lifespan in progeria are largely determined by the total amount of farnesylated progerin and the ratio of progerin to mature lamin A [6,7].